Senator Hassan Investigation Forces Big Pharma Company to Abandon Monopoly & Egregious Price Hike Strategy, Allowing Lower-Cost Generic Inhaler for Kids to Enter Market
March 16, 2026
March 16, 2026
WASHINGTON, March 16 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
* * *
Senator Hassan Investigation Forces Big Pharma Company to Abandon Monopoly & Egregious Price Hike Strategy, Allowing Lower-Cost Generic Inhaler for Kids to Enter Market
*
Hassan Investigative Report Details How Kids Suffered While the Company Profited
New FDA Approved Generic Will Enable More Kids to Get Asthma Treatment They . . .
* * *
Senator Hassan Investigation Forces Big Pharma Company to Abandon Monopoly & Egregious Price Hike Strategy, Allowing Lower-Cost Generic Inhaler for Kids to Enter Market
*
Hassan Investigative Report Details How Kids Suffered While the Company Profited
New FDA Approved Generic Will Enable More Kids to Get Asthma Treatment They . . .
